MONASH IVF GROUP LIMITED — Director's Dealing 2020

May 31, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Monash IVF Group Limited

ABN 90 169 302 309

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Note that this appendix 3Y notice updates the Appendix 3Y notice lodged on 11 August 2014 and now includes Part 3

Name of Director	Richard Charles Henshaw
Date of last notice	23 October 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Richard Charles Henshaw <Richgill FamilyTrust A/C>
Date of change	(a) 27 May 2020(b) 18 October 2019 (refer to attachedletter)
No. of securities held prior to change	1,026,622
Class	Ordinary Shares
Number acquired	(a) 335,517
Number disposed	(b) 3,297
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	(a) $174,468.84(b) $3,395.91

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	1,358,842 Ordinary Shares
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back	(a) Participation in the retail component ofthe accelerated non-renounceable pro-rata entitlement offer announced to theASX on 27 April 2020(b) On-market

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 322] intentionally omitted <==

----- Start of picture text ----- Detail of contract n/aNature of interest n/aName of registered holder n/a(if issued securities)Date of change n/aNo. and class of securities to which n/ainterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changedInterest acquired n/aInterest disposed n/aValue/Consideration n/aNote: If consideration is non-cash, provide detailsand an estimated valuationInterest after change n/a----- End of picture text -----

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior written**clearance was required? **	No
If so, was prior written clearance provided to allow the tradeto proceed during this period?	n/a
If prior written clearance was provided, on what date was thisprovided?	n/a

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

==> picture [596 x 93] intentionally omitted <==

1 June 2020

Mr Corey Lian Adviser, Listing Compliance (Sydney) ASX Limited 20 Bridge Street Sydney NSW 2000

Dear Mr Lian

Monash IVF Group Limited (Company) – Appendix 3Y (23 October 2019)

We refer to the Appendix 3Y for Mr Richard Charles Henshaw lodged on 23 October 2019. The Appendix 3Y included 385,010 shares sold between 11 October 2019 and 22 October 2019 and it has been identified that a further 3,297 shares were sold on 18 October 2019 and not included in the Appendix 3Y lodged on 23 October 2019.

The Company acknowledges that the non-disclosure of the transaction was an inadvertent breach of the Company’s obligations due to an internal administrative oversight. Upon identification by the Company, the attached Appendix 3Y includes disclosure of the transaction on 18 October 2019.

The Company and its directors take their obligations seriously and all directors have been reminded of their obligation to keep the Company informed of any changes to their interests in the Company or circumstances giving rise to a disclosure obligation under Listing Rule 3.19A within 5 business days of such change occurring.

The Company is satisfied that current arrangements in place are adequate to ensure compliance with the Listing Rule 3.19B.

Yours Sincerely

==> picture [113 x 47] intentionally omitted <==

Malik Jainudeen Chief Financial Officer and Company Secretary